Insider Transactions in Q1 2024 at Quidel Ortho Corp (QDEL)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2024
|
Michael S. Iskra EVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,773
-11.0%
|
$83,331
$47.94 P/Share
|
|
Mar 28
2024
|
Michael S. Iskra EVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
4,925
+23.4%
|
-
|
|
Mar 28
2024
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
879
-6.14%
|
$41,313
$47.94 P/Share
|
|
Mar 28
2024
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
2,462
+14.67%
|
-
|
|
Mar 28
2024
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,801
-4.79%
|
$84,647
$47.94 P/Share
|
|
Mar 28
2024
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
3,811
+9.21%
|
-
|
|
Mar 28
2024
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,805
-5.93%
|
$131,835
$47.94 P/Share
|
|
Mar 28
2024
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
4,925
+9.43%
|
-
|
|
Mar 28
2024
|
Joseph M Busky Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,234
-24.62%
|
$104,998
$47.94 P/Share
|
|
Mar 28
2024
|
Joseph M Busky Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,925
+35.18%
|
-
|
|
Feb 23
2024
|
Joseph M Busky Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
2,150
+50.0%
|
$98,900
$46.35 P/Share
|
|
Feb 14
2024
|
Louise Brandy SVP, Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-13.6%
|
$8,730
$45.27 P/Share
|
|
Feb 10
2024
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
755
-0.88%
|
$51,340
$68.15 P/Share
|
|
Feb 10
2024
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,367
+1.57%
|
-
|
|
Feb 03
2024
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,924
-0.35%
|
$130,832
$68.34 P/Share
|
|
Feb 03
2024
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,795
+0.68%
|
-
|
|
Feb 03
2024
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
946
-2.21%
|
$64,328
$68.34 P/Share
|
|
Feb 03
2024
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
1,660
+3.74%
|
-
|
|
Feb 01
2024
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
566
-0.1%
|
$39,054
$69.45 P/Share
|
|
Feb 01
2024
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,116
+0.2%
|
-
|
|
Feb 01
2024
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
501
-1.21%
|
$34,569
$69.45 P/Share
|
|
Feb 01
2024
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
879
+2.07%
|
-
|
|
Feb 01
2024
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-1.41%
|
$11,661
$69.45 P/Share
|
|
Feb 01
2024
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
473
+3.78%
|
-
|
|
Feb 01
2024
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-1.97%
|
$46,920
$69.45 P/Share
|
|
Feb 01
2024
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
1,313
+3.67%
|
-
|
|
Jan 31
2024
|
Michelle A. Hodges SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,378
-5.4%
|
$161,704
$68.51 P/Share
|
|
Jan 31
2024
|
Michelle A. Hodges SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,462
+11.98%
|
-
|
|
Jan 31
2024
|
Werner Kroll SVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
3,752
-5.5%
|
$255,136
$68.51 P/Share
|
|
Jan 31
2024
|
Werner Kroll SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
7,175
+9.51%
|
-
|
|
Jan 31
2024
|
Douglas C Bryant President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,430
-0.68%
|
$505,240
$68.51 P/Share
|
|
Jan 31
2024
|
Douglas C Bryant President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,854
+1.69%
|
-
|
|
Jan 31
2024
|
Robert Joseph Bujarski EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,781
-6.75%
|
$393,108
$68.51 P/Share
|
|
Jan 31
2024
|
Robert Joseph Bujarski EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct |
9,991
+10.35%
|
-
|